目的 Acute graft-versus-host disease (aGVHD) remains a significant cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation recipients.Additionally, it is unclear which tre
目的 Background and Objective: Cyclosporine A (CsA) has been used as immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation (HSCT) for about 30 years.
目的 Objectives: To compare the effects of the use of alloSCT from a matched sibling donor which includes single alloSCT, non-myeloablative alloSCT and prior ASCT followed by non-myeloablative alloSCT f
目的 This review discusses recent insights into the role, mechanism, clinical applications, differences and the fundamental interactions of G-CSF and AMD3100 in stem cell mobilisation and chemotherapy f
目的 The detection of fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) has been used as a powerful adverse prognostic indicator for acute myeloid leukemia (AML) in any age group.
目的 To perform a meta-analysis of all studies comparing Antithymocyte globulin (ATG) and alemtuzumab or graft-versus-host disease (GVHD) prophylaxis in allogeneic haematopoietic stem cell transplantati
目的 Chemotherapy can increase treatment-related mortality associated with future hematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukemia (AML) There
目的 To explore the role of reduced-intensity conditioning therapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and Myelodysplastic syndrome.